Kim Kardashian And Sharon Osbourne's Influence Leads To Ozempic-Inspired Dishes In Hollywood Restaurants

Restaurants in Hollywood are now offering special ‘Ozempic dishes’ in response to the popular weight-loss drug’s impact on eating habits.

The drug, which has been linked to rapid weight loss in stars such as Kim Kardashian and actress Christina Hendricks, has led to a shift towards smaller portion sizes and luxury food items.

What Happened: According to a report by the Daily Mail, restaurants in Beverly Hills are adapting their menus to cater to the changing appetites of customers on Ozempic.

The drug, also known as the ‘skinny jab’, is a brand name for the diabetes drug semaglutide. It is taken as a weekly injection and has been reported to help users feel full faster, leading to weight loss.

Billionaire Elon Musk and TV personality Sharon Osbourne have both publicly acknowledged their use of the drug for weight loss.

See Also: Lisa Marie Presley’s Autopsy Prompts Expert To Warn About ‘Miracle’ Weight Loss Drug Ozempic

Why It Matters: The trend of using Ozempic for weight loss has raised concerns among health professionals and celebrities alike. The European Union's drug regulator has expanded its investigation into the risk of suicidal thoughts and self-injury among patients taking weight loss and diabetes medications, including Ozempic.

Additionally, celebrities such as Amy Schumer and Raven-Symoné have voiced their concerns about the misuse of the drug for weight loss purposes.

Read Next: European Medicines Agency Says The Review Of Novo’s Drugs Ozempic, Saxenda, Wegovy Started On 3 July

Image via Shutterstock


Engineered by Benzinga Neuro, Edited by Pooja Rajkumari


The GPT-4 Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!